Razvan Simionescu

Diversity of Catalysis by an Imido-Hydrido Complex of Molybdenum. Mechanism of Carbonyl Hydrosilylation and Silane Alcoholysis

New Imido hydride complex 1 catalyzes a variety of silylation reactions that proceed via initial substrate activation but not silane addition.

Completion of the seven-step pathway from tabersonine to the anticancer drug precursor vindoline and its assembly in yeast

Significance Bioinformatics and virus-induced gene silencing (VIGS)-guided gene discovery combined with biochemical enzyme assays show that tabersonine 3-oxygenase (T3O) and tabersonine 3-reductase (T3R) are required to form 3-hydroxy-16-methoxy-2,3-dihydrotabersonine, an intermediate in the formation of anticancer drug precursor vindoline from tabersonine. In the absence of T3R, tabersonine is converted by T3O to a series of byproducts that can no longer be used by T3R, suggesting a concerted reaction mechanism. Engineering the seven-gene pathway in yeast demonstrated a prototype platform of high potential for industrial production of the anticancer drug precursor vindoline. Antitumor substances related to vinblastine and vincristine are exclusively found in the Catharanthus roseus (Madagascar periwinkle), a member of the Apocynaceae plant family, and continue to be extensively used in cancer chemotherapy. Although in high demand, these valuable compounds only accumulate in trace amounts in C. roseus leaves. Vinblastine and vincristine are condensed from the monoterpenoid indole alkaloid (MIA) precursors catharanthine and vindoline. Although catharanthine biosynthesis remains poorly characterized, the biosynthesis of vindoline from the MIA precursor tabersonine is well understood at the molecular and biochemical levels. This study uses virus-induced gene silencing (VIGS) to identify a cytochrome P450 [CYP71D1V2; tabersonine 3-oxygenase (T3O)] and an alcohol dehydrogenase [ADHL1; tabersonine 3-reductase (T3R)] as candidate genes involved in the conversion of tabersonine or 16-methoxytabersonine to 3-hydroxy-2,3-dihydrotabersonine or 3-hydroxy-16-methoxy-2,3-dihydrotabersonine, which are intermediates in the vindorosine and vindoline pathways, respectively. Biochemical assays with recombinant enzymes confirm that product formation is only possible by the coupled action of T3O and T3R, as the reaction product of T3O is an epoxide that is not used as a substrate by T3R. The T3O and T3R transcripts were identified in a C. roseus database representing genes preferentially expressed in leaf epidermis and suggest that the subsequent reaction products are transported from the leaf epidermis to specialized leaf mesophyll idioblast and laticifer cells to complete the biosynthesis of these MIAs. With these two genes, the complete seven-gene pathway was engineered in yeast to produce vindoline from tabersonine.

Mechanistic Aspects of Hydrosilylation Catalyzed by (ArN=)Mo(H)(Cl)(PMe3)3

The reaction of (ArN=)MoCl(2)(PMe(3))(3) (Ar = 2,6-diisopropylphenyl) with L-Selectride gives the hydrido-chloride complex (ArN=)Mo(H)(Cl)(PMe(3))(3) (2). Complex 2 was found to catalyze the hydrosilylation of carbonyls and nitriles as well as the dehydrogenative silylation of alcohols and water. Compound 2 does not show any productive reaction with PhSiH(3); however, a slow H/D exchange and formation of (ArN=)Mo(D)(Cl)(PMe(3))(3) (2(D)) was observed upon addition of PhSiD(3). Reactivity of 2 toward organic substrates was studied. Stoichiometric reactions of 2 with benzaldehyde and cyclohexanone start with dissociation of the trans-to-hydride PMe(3) ligand followed by coordination and insertion of carbonyls into the Mo-H bond to form alkoxy derivatives (ArN=)Mo(Cl)(OR)(PMe(2))L(2) (3: R = OCH(2)Ph, L(2) = 2 PMe(3); 5: R = OCH(2)Ph, L(2) = η(2)-PhC(O)H; 6: R = OCy, L(2) = 2 PMe(3)). The latter species reacts with PhSiH(3) to furnish the corresponding silyl ethers and to recover the hydride 2. An analogous mechanism was suggested for the dehydrogenative ethanolysis with PhSiH(3), with the key intermediate being the ethoxy complex (ArN=)Mo(Cl)(OEt)(PMe(3))(3) (7). In the case of hydrosilylation of acetophenone, a D-labeling experiment, i.e., a reaction of 2 with acetophenone and PhSiD(3) in the 1:1:1 ratio, suggests an alternative mechanism that does not involve the intermediacy of an alkoxy complex. In this particular case, the reaction presumably proceeds via Lewis acid catalysis. Similar to the case of benzaldehyde, treatment of 2 with styrene gives trans-(ArN=)Mo(H)(η(2)-CH(2)═CHPh)(PMe(3))(2) (8). Complex 8 slowly decomposes via the release of ethylbenzene, indicating only a slow insertion of styrene ligand into the Mo-H bond of 8.

The unexpected mechanism of carbonyl hydrosilylation catalyzed by (Cp)(ArN[double bond, length as m-dash])Mo(H)(PMe(3)).

Complex (Cp)(ArN[double bond, length as m-dash])Mo(H)(PMe(3)) (2, Ar = 2,6-diisopropylphenyl) catalyzes the hydrosilylation of carbonyls by an unexpected associative mechanism. Complex 2 also reacts with PhSiH(3) by a σ-bond metathesis mechanism to give the silyl derivative (Cp)(ArN[double bond, length as m-dash])Mo(SiH(2)Ph)(PMe(3)).

An unexpected mechanism of hydrosilylation by a silyl hydride complex of molybdenum.

Carbonyl hydrosilylation catalyzed by (ArN)Mo(H)(SiH(2)Ph)(PMe(3))(3) (3) is unusual in that it does not involve the expected Si-O elimination from intermediate (ArN)Mo(SiH(2)Ph)(O(i)Pr)(PMe(3))(2) (7). Instead, 7 reversibly transfers β-CH hydrogen from the alkoxide ligand to metal.

Agostic NSiH⋅⋅⋅Mo Complexes: From Curiosity to Catalysis

2a,b with a d configuration (Scheme 1). Bonding in these species can be represented by two canonical forms (B and C ; Scheme 1), one of which has a silanimine character (C). This fact suggests that 1 and 2a,b could serve as intermediates for silanimine complexes, which, although very scarce, are known to exhibit a wealth of reactivity. Herein, we describe the preparation, structure, and reactivity of a new agostic silylamido complex, 3. For the first time, we report the catalytic and stoichiometric reactions of such a complex and provide evidence for the intermediacy of a silanimine complex. The reaction of bis(imido) compound (ArN)2Mo(PMe3)3 (Ar= 2,6-diisopropylphenyl) with two equivalents of PhSiH3 leads to a product of double silane addition, the b-agostic NSi H···Mo complex 3 [Eq. (1)]. The structure of 3 is fluxional at room temperature, but at 223 K the H NMR spectrum shows an up-field signal characteristic of the proton of an agostic Si Ha moiety at d = 4.35 ppm (brm), which is coupled to a signal assigned to the terminal Si H proton at d = 6.03 ppm (d, JH,H = 5.4 Hz). The diastereotopic protons

Assignment of the 1H and 13C NMR of tocotrienols.

Vitamin E is a family of chromanols that vary by the degree of methylation of the chroman ring as well as the nature of the hydrophobic side chain at C2 that serves to anchor these lipids in biological membranes. The tocopherols contain saturated side chains, whereas the tocotrienols contain three sites of unsaturation and are derived from geranylgeranyl diphosphate. A growing interest in the unique biological activities of the tocotrienols has led us to begin syntheses of isotopically substituted forms and other derivatives that will be useful for probing the metabolism and membrane behavior of the tocotrienols. In order to be certain of our ability to selectively modify sites on the parent molecules it was necessary to make as complete an assignment of the 1H and 13C NMR as possible. Herein we report multidimensional NMR data (HSQC, COSY, ADEQUATE(1,1), CH HMBC, and NOESY) that have allowed us to assign the identity of almost all the resonances for α‐, β‐, γ‐, and δ‐tocotrienol. Copyright

Design of thermally stable versions of the burgess reagent: stability and reactivity study.

Three new versions of the Burgess reagent were synthesized and their thermal stability investigated by NMR. The new reagents exhibited improved reactivity toward epoxides, diols, and vinyl oxiranes as compared with the original version.

A detailed NMR- and DFT-based study of the Sakurai-Hosomi-Yamamoto asymmetric allylation reaction.

A Lewis acid complex between benzaldehyde and the silver catalyst was detected by (31)P NMR and shown to be the direct precursor to allylation within the Sakurai-Hosomi-Yamamoto reaction. Structural and thermochemical hybrid-DFT calculations indicated that benzaldehyde predominantly formed an η(1)-σ-complex with the catalyst; however, two other competing conformers involving different coordination modes were found, including an activated μ(2)-bound complex. The differences in (31)P NMR shifts upon complexation were calculated by the gauge-independent atomic orbital (GIAO-DFT) method for each conformer. The minimum energy conformer was found to correlate well with chemical shift trends observed experimentally, and an analysis of Mullikan charge populations revealed that the carbonyl carbon of the highest-energy conformer was the most electron-deficient. Furthermore, one minor and three major silicon intermediates were detected by (29)Si NMR and, with the aid of (1)H-(29)Si HSQC, were assigned by comparison with parent compounds and GIAO-DFT calculations. Finally, a tentative mechanism was proposed based on these findings.

Solution of the multistep pathway for assembly of corynanthean, strychnos, iboga, and aspidosperma monoterpenoid indole alkaloids from 19E-geissoschizine

Significance The multistep assembly of catharanthine and tabersonine from strictosidine remains poorly characterized for understanding the biochemistry of anticancer monoterpenoid indole alkaloid (MIA) biosynthesis in the medicinal plant, Catharanthus roseus. The seven-step pathway from 19E-geissoschizine to four major MIA skeletons enables the assembly of catharanthine and tabersonine that complete the pathway for biosynthesis of the anticancer drugs, anhydrovinblastine and vincristine as well as for production of other biologically active MIAs. Monoterpenoid indole alkaloids (MIAs) possess a diversity of alkaloid skeletons whose biosynthesis is poorly understood. A bioinformatic search of candidate genes, combined with their virus-induced gene silencing, targeted MIA profiling and in vitro/in vivo pathway reconstitution identified and functionally characterized six genes as well as a seventh enzyme reaction required for the conversion of 19E-geissoschizine to tabersonine and catharanthine. The involvement of pathway intermediates in the formation of four MIA skeletons is described, and the role of stemmadenine-O-acetylation in providing necessary reactive substrates for the formation of iboga and aspidosperma MIAs is described. The results enable the assembly of complex dimeric MIAs used in cancer chemotherapy and open the way to production of many other biologically active MIAs that are not easily available from nature.